Co-Authors
This is a "connection" page, showing publications co-authored by JAVIER A ADACHI and RAY Y HACHEM.
Connection Strength
0.393
-
Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution. Medicine (Baltimore). 2009 Jul; 88(4):211-220.
Score: 0.085
-
The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients. Am J Infect Control. 2009 Aug; 37(6):442-6.
Score: 0.082
-
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife. 2023 01 30; 12.
Score: 0.055
-
Neutropenic Enterocolitis: Clinical Features and Outcomes. Dis Colon Rectum. 2020 03; 63(3):381-388.
Score: 0.045
-
Improvement in the diagnosis of catheter-related bloodstream infections in a tertiary cancer center. Am J Infect Control. 2017 Mar 01; 45(3):e34-e39.
Score: 0.036
-
Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center. Oncologist. 2012; 17(10):1329-36.
Score: 0.026
-
Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents. 2010 Aug; 36(2):182-6.
Score: 0.023
-
Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infect Control. 2009 Nov; 37(9):741-5.
Score: 0.021
-
The role of vitamin B6 in the prevention of haematological toxic effects of linezolid in patients with cancer. J Antimicrob Chemother. 2008 Feb; 61(2):421-4.
Score: 0.019